Johansson LO - Search Results

1

Renal T(*)(2) perfusion using an iron oxide nanoparticle contrast agent--influence of T(1) relaxation on the first-pass response.

Bjørnerud A, Johansson LO, Ahlström HK. Bjørnerud A, et al. Among authors: johansson lo. Magn Reson Med. 2002 Feb;47(2):298-304. doi: 10.1002/mrm.10058. Magn Reson Med. 2002. PMID: 11810673 Free article.

2

Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state--dependence on blood volume and water exchange.

Bjørnerud A, Johansson LO, Briley-Saebø K, Ahlström HK. Bjørnerud A, et al. Among authors: johansson lo. Magn Reson Med. 2002 Mar;47(3):461-71. doi: 10.1002/mrm.10066. Magn Reson Med. 2002. PMID: 11870832 Free article.

3

Quantification of renal perfusion abnormalities using an intravascular contrast agent (part 2): results in animals and humans with renal artery stenosis.

Schoenberg SO, Aumann S, Just A, Bock M, Knopp MV, Johansson LO, Ahlstrom H. Schoenberg SO, et al. Among authors: johansson lo. Magn Reson Med. 2003 Feb;49(2):288-98. doi: 10.1002/mrm.10383. Magn Reson Med. 2003. PMID: 12541249 Free article.

4

Assessment of myocardial blood volume and water exchange: theoretical considerations and in vivo results.

Bjørnerud A, Bjerner T, Johansson LO, Ahlström HK. Bjørnerud A, et al. Among authors: johansson lo. Magn Reson Med. 2003 May;49(5):828-37. doi: 10.1002/mrm.10430. Magn Reson Med. 2003. PMID: 12704765 Free article.

5

A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution.

Johansson LO, Bjørnerud A, Ahlström HK, Ladd DL, Fujii DK. Johansson LO, et al. J Magn Reson Imaging. 2001 Apr;13(4):615-8. doi: 10.1002/jmri.1086. J Magn Reson Imaging. 2001. PMID: 11276107

6

Pre-clinical results with Clariscan (NC100150 Injection); experience from different disease models.

Bjørnerud A, Johansson LO, Ahlström HK. Bjørnerud A, et al. Among authors: johansson lo. MAGMA. 2001 May;12(2-3):99-103. doi: 10.1007/BF02668090. MAGMA. 2001. PMID: 11390264

7

Effect of NC100150 injection on the (1)H NMR linewidth of human whole blood ex vivo: dependency on blood oxygen tension.

Bjørnerud A, Briley-Saebø K, Johansson LO, Kellar KE. Bjørnerud A, et al. Among authors: johansson lo. Magn Reson Med. 2000 Nov;44(5):803-7. doi: 10.1002/1522-2594(200011)44:5<803::aid-mrm19>3.0.co;2-k. Magn Reson Med. 2000. PMID: 11064416 Free article.

8

Utility of NC100150 injection in cardiac MRI.

Johansson LO, Bjerner T, Bjornerud A, Ahlstrom H, Tarlo KS, Lorenz CH. Johansson LO, et al. Acad Radiol. 2002 May;9 Suppl 1:S79-81. doi: 10.1016/s1076-6332(03)80404-x. Acad Radiol. 2002. PMID: 12019903 No abstract available.

9

Acute cardiac transplant rejection: detection and grading with MR imaging with a blood pool contrast agent--experimental study in the rat.

Johansson L, Johnsson C, Penno E, Björnerud A, Ahlström H. Johansson L, et al. Radiology. 2002 Oct;225(1):97-103. doi: 10.1148/radiol.2251010698. Radiology. 2002. PMID: 12354991

10

High in-plane resolution T2-weighted magnetic resonance imaging of acute myocardial ischemia in pigs using the intravascular contrast agent NC100150 injection.

Bjerner T, Wikström G, Johansson L, Ahlström H. Bjerner T, et al. Invest Radiol. 2004 Aug;39(8):470-8. doi: 10.1097/01.rli.0000129153.64225.7f. Invest Radiol. 2004. PMID: 15257208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters